Banks - Regional
Compare Stocks
4 / 10Stock Comparison
CARE vs UVSP vs NBTB vs MNSB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
CARE vs UVSP vs NBTB vs MNSB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $580M | $1.10B | $2.35B | $176M |
| Revenue (TTM) | $255M | $518M | $867M | $136M |
| Net Income (TTM) | $31M | $91M | $169M | $16M |
| Gross Margin | 61.7% | 61.0% | 72.1% | 54.4% |
| Operating Margin | 15.7% | 21.9% | 25.3% | 14.0% |
| Forward P/E | 4.8x | 11.1x | 10.8x | 10.4x |
| Total Debt | $179M | $352M | $327M | $70M |
| Cash & Equiv. | $105M | $554M | $185M | $25M |
CARE vs UVSP vs NBTB vs MNSB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| Univest Financial C… (UVSP) | 100 | 234.7 | +134.7% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| MainStreet Bancshar… (MNSB) | 100 | 177.2 | +77.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs UVSP vs NBTB vs MNSB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 6.2%, EPS growth 32.1%
- Lower P/E (4.8x vs 10.4x)
- Beta 0.56 vs UVSP's 1.01
- +69.0% vs NBTB's +9.0%
UVSP is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 140.1% 10Y total return vs CARE's 112.9%
- PEG 0.76 vs NBTB's 1.53
- Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs NBTB's 0.5%
NBTB is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- Lower volatility, beta 0.89, Low D/E 17.3%, current ratio 1.60x
- Beta 0.89, yield 3.2%, current ratio 1.60x
- 10.4% NII/revenue growth vs MNSB's -1.4%
MNSB is the clearest fit if your priority is bank quality.
- NIM 3.1% vs CARE's 2.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (4.8x vs 10.4x) | |
| Quality / Margins | Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs UVSP's 1.01 | |
| Dividends | 3.2% yield, 12-year raise streak, vs UVSP's 2.3%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs NBTB's 0.5% |
CARE vs UVSP vs NBTB vs MNSB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs UVSP vs NBTB vs MNSB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
UVSP leads 2 • CARE leads 0 • MNSB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 6.4x MNSB's $136M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $255M | $518M | $867M | $136M |
| EBITDAEarnings before interest/tax | $46M | $119M | $241M | $23M |
| Net IncomeAfter-tax profit | $31M | $91M | $169M | $16M |
| Free Cash FlowCash after capex | $30M | $92M | $225M | $13M |
| Gross MarginGross profit ÷ Revenue | +61.7% | +61.0% | +72.1% | +54.4% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +21.9% | +25.3% | +14.0% |
| Net MarginNet income ÷ Revenue | +12.3% | +17.5% | +19.5% | +11.5% |
| FCF MarginFCF ÷ Revenue | +12.5% | +18.7% | +25.2% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +23.1% | +39.5% | +120.9% |
Valuation Metrics
UVSP leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.2x trailing earnings, UVSP trades at a 35% valuation discount to CARE's 18.7x P/E. Adjusting for growth (PEG ratio), UVSP offers better value at 0.84x vs NBTB's 1.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $580M | $1.1B | $2.4B | $176M |
| Enterprise ValueMkt cap + debt − cash | $654M | $897M | $2.5B | $221M |
| Trailing P/EPrice ÷ TTM EPS | 18.71x | 12.21x | 13.53x | 13.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.77x | 11.10x | 10.80x | 10.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.84x | 1.92x | — |
| EV / EBITDAEnterprise value multiple | 16.34x | 7.49x | 10.35x | 11.58x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.12x | 2.71x | 1.30x |
| Price / BookPrice ÷ Book value/share | 1.40x | 1.18x | 1.21x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 18.25x | 11.34x | 10.75x | 16.57x |
Profitability & Efficiency
UVSP leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
UVSP delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $7 for MNSB. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +9.8% | +9.5% | +7.3% |
| ROA (TTM)Return on assets | +0.7% | +1.1% | +1.1% | +0.7% |
| ROICReturn on invested capital | +5.7% | +6.5% | +7.9% | +5.0% |
| ROCEReturn on capital employed | +1.5% | +8.8% | +2.4% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.43x | 0.37x | 0.17x | 0.32x |
| Net DebtTotal debt minus cash | $73M | -$202M | $142M | $45M |
| Cash & Equiv.Liquid assets | $105M | $554M | $185M | $25M |
| Total DebtShort + long-term debt | $179M | $352M | $327M | $70M |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.60x | 1.05x | 0.31x |
Total Returns (Dividends Reinvested)
Evenly matched — CARE and UVSP each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $12,056 for MNSB. Over the past 12 months, CARE leads with a +69.0% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors UVSP at 33.4% vs MNSB's 6.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.8% | +20.9% | +9.3% | +19.4% |
| 1-Year ReturnPast 12 months | +69.0% | +32.0% | +9.0% | +26.4% |
| 3-Year ReturnCumulative with dividends | +94.7% | +137.1% | +54.1% | +21.5% |
| 5-Year ReturnCumulative with dividends | +87.2% | +46.4% | +29.9% | +20.6% |
| 10-Year ReturnCumulative with dividends | +112.9% | +140.1% | +102.2% | +126.9% |
| CAGR (3Y)Annualised 3-year return | +24.9% | +33.4% | +15.5% | +6.7% |
Risk & Volatility
Evenly matched — CARE and UVSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than UVSP's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UVSP currently trades 98.8% from its 52-week high vs MNSB's 93.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 1.01x | 0.89x | 0.66x |
| 52-Week HighHighest price in past year | $26.58 | $39.06 | $46.92 | $25.17 |
| 52-Week LowLowest price in past year | $15.37 | $27.91 | $39.20 | $17.86 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +98.8% | +96.1% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 75.4 | 68.1 | 57.3 | 50.4 |
| Avg Volume (50D)Average daily shares traded | 276K | 180K | 236K | 58K |
Analyst Outlook
NBTB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CARE as "Buy", UVSP as "Hold", NBTB as "Hold", MNSB as "Hold". Consensus price targets imply 3.1% upside for CARE (target: $27) vs -11.9% for UVSP (target: $34). For income investors, NBTB offers the higher dividend yield at 3.17% vs UVSP's 2.28%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $27.00 | $34.00 | $46.00 | — |
| # AnalystsCovering analysts | 4 | 6 | 10 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +2.3% | +3.2% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 12 | 2 |
| Dividend / ShareAnnual DPS | — | $0.88 | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +3.2% | +0.4% | 0.0% |
NBTB leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). UVSP leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
CARE vs UVSP vs NBTB vs MNSB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CARE or UVSP or NBTB or MNSB a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). Univest Financial Corporation (UVSP) offers the better valuation at 12. 2x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or UVSP or NBTB or MNSB?
On trailing P/E, Univest Financial Corporation (UVSP) is the cheapest at 12.
2x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Univest Financial Corporation wins at 0. 76x versus NBT Bancorp Inc. 's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CARE or UVSP or NBTB or MNSB?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to +20. 6% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: UVSP returned +140. 1% versus NBTB's +102. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or UVSP or NBTB or MNSB?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus Univest Financial Corporation's 1. 01β — meaning UVSP is approximately 80% more volatile than CARE relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or UVSP or NBTB or MNSB?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or UVSP or NBTB or MNSB?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or UVSP or NBTB or MNSB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Univest Financial Corporation (UVSP) is the more undervalued stock at a PEG of 0. 76x versus NBT Bancorp Inc. 's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 1x for Univest Financial Corporation — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 1% to $27. 00.
08Which pays a better dividend — CARE or UVSP or NBTB or MNSB?
In this comparison, NBTB (3.
2% yield), UVSP (2. 3% yield) pay a dividend. CARE, MNSB do not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or UVSP or NBTB or MNSB better for a retirement portfolio?
For long-horizon retirement investors, NBT Bancorp Inc.
(NBTB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 3. 2% yield, +102. 2% 10Y return). Both have compounded well over 10 years (NBTB: +102. 2%, MNSB: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and UVSP and NBTB and MNSB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CARE is a small-cap quality compounder stock; UVSP is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; MNSB is a small-cap deep-value stock. UVSP, NBTB pay a dividend while CARE, MNSB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.